CHIARLE, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 6.751
EU - Europa 4.606
AS - Asia 2.154
AF - Africa 47
OC - Oceania 26
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 6
Totale 13.601
Nazione #
US - Stati Uniti d'America 6.651
CN - Cina 1.215
IT - Italia 823
SE - Svezia 618
IE - Irlanda 522
DE - Germania 481
UA - Ucraina 428
DK - Danimarca 404
SG - Singapore 363
FR - Francia 321
FI - Finlandia 302
KR - Corea 221
AT - Austria 209
GB - Regno Unito 155
PL - Polonia 135
CA - Canada 95
VN - Vietnam 89
JP - Giappone 88
IN - India 51
BE - Belgio 47
ES - Italia 41
SN - Senegal 39
ID - Indonesia 30
AU - Australia 24
TW - Taiwan 22
NL - Olanda 21
RU - Federazione Russa 20
GR - Grecia 17
HK - Hong Kong 15
RO - Romania 13
PT - Portogallo 12
PK - Pakistan 11
TR - Turchia 10
PH - Filippine 9
BY - Bielorussia 8
IR - Iran 8
CH - Svizzera 7
CZ - Repubblica Ceca 5
EU - Europa 5
MX - Messico 5
BR - Brasile 4
UZ - Uzbekistan 4
EG - Egitto 3
HU - Ungheria 3
MY - Malesia 3
NO - Norvegia 3
TH - Thailandia 3
AR - Argentina 2
CL - Cile 2
IL - Israele 2
KW - Kuwait 2
MU - Mauritius 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
OM - Oman 2
PE - Perù 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CO - Colombia 1
EE - Estonia 1
HR - Croazia 1
IM - Isola di Man 1
JO - Giordania 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MO - Macao, regione amministrativa speciale della Cina 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
Totale 13.601
Città #
Chandler 1.006
Ann Arbor 735
Beijing 731
Dublin 522
Houston 409
Ashburn 316
Jacksonville 300
Fairfield 291
Singapore 262
Torino 245
Nyköping 208
Wilmington 208
Vienna 207
Villeurbanne 199
Medford 173
Princeton 164
Dearborn 154
Woodbridge 147
Warsaw 126
Cambridge 114
Seattle 110
Los Angeles 107
Fremont 88
Pisa 86
Guangzhou 70
Turin 69
Boston 66
Shanghai 66
Dong Ket 63
Boardman 61
Redwood City 61
Milan 57
Nanjing 40
Verona 39
Toronto 37
Brussels 35
Falls Church 35
Santa Clara 35
Tokyo 31
Jakarta 29
Munich 25
Washington 25
Norwalk 23
Pune 21
Hefei 20
Lachine 20
Rome 20
New York 19
Wuhan 19
Hangzhou 18
San Mateo 18
Düsseldorf 17
Grafing 17
Taipei 17
San Diego 16
Chengdu 15
Helsinki 13
Montréal 13
Silver Spring 13
Chongqing 12
Detroit 12
Phoenix 12
Duncan 11
Jinan 11
Mountain View 11
Ottawa 10
Shenyang 10
Xian 10
Athens 9
Barcelona 9
Changsha 9
Jülich 9
Kunming 9
Buffalo 8
Des Moines 8
Fuzhou 8
Palaiseau 8
Seoul 8
Bologna 7
Chicago 7
Nanchang 7
Nürnberg 7
Occimiano 7
Philadelphia 7
Redmond 7
Tianjin 7
Zhengzhou 7
Fountain Valley 6
Frankfurt am Main 6
Hebei 6
London 6
New Haven 6
Upper Marlboro 6
Amsterdam 5
Auburn Hills 5
Berlin 5
El Paso 5
Lissone 5
Madrid 5
Saga 5
Totale 8.369
Nome #
Vaccination with ENO1 DNA Prolongs Survival of Genetically Engineered Mice with Pancreatic Cancer. 427
A theranostic approach based on the use of a dual boron/Gd agent to improve the efficacy of Boron Neutron Capture Therapy in the lung cancer treatment 378
Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells 366
Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjects. 332
Thymic epithelial tumors express vascular endothelial growth factors and their receptors as potential targets of antiangiogenic therapy: A tissue micro array-based multicenter study. 279
p130Cas mediates the transforming properties of the anaplastic lymphoma kinase 243
Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency 239
Negative feedback regulation of Rac in leukocytes from mice expressing a constitutively active phosphatidylinositol 3-kinase gamma 237
The anaplastic lymphoma kinase controls cell shape and growth of anaplastic large cell lymphoma through Cdc42 activation 224
Efficacy of a Cancer Vaccine against ALK-Rearranged Lung Tumors 214
Leukocyte transmigration is modulated by chemokine-mediated PI3Kgamma-dependent phosphorylation of vimentin 212
Calming down T cell acute leukemia. 202
Editing of mouse and human immunoglobulin genes by CRISPR-Cas9 system 201
Hepatocyte Growth Factor-mediated satellite cells niche perturbation promotes development of distinct sarcoma subtypes 195
Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma 190
Redundant and non-redundant roles for Cdc42 and Rac1 in lymphomas developed in NPM-ALK transgenic mice 183
STAT3 activity is necessary and sufficient for the development of immune-mediated myocarditis in mice and promotes progression to dilated cardiomyopathy 183
Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models. 181
Heat shock protein expression in early diabetic nephropathy 154
Espressione delle Heat Shock Proteins nella nefropatia diabetica sperimentale 152
Expression of angiogenesis-related biomarkers in thymic epithelial tumors (TET). 148
Heat shock protein expression in diabetic nephropathy 146
Maternal immunization: New perspectives on its application against non-infectious related diseases in newborns 141
Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia 138
Mitotic Spindle Assembly and Genomic Stability in Breast Cancer Require PI3K-C2α Scaffolding Function 138
An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma associated antigen 136
Inter- and intratumoral heterogeneity of BCL2 correlates with IgH expression and prognosis in follicular lymphoma 128
The EGFR family members sustain the neoplastic phenotype of ALK+ lung adenocarcinoma via EGR1. 127
The BRAF pseudogene functions as a competitive endogenous RNA and induces lymphoma in vivo 125
Anaplastic lymphoma kinase in human cancer 117
Conditional activation of met in differentiated skeletal muscle induces atrophy 116
The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL 113
The STAT3 isoforms alpha and beta have unique and specific functions 112
Autoantibody signature in human ductal pancreatic adenocarcinoma 109
Quantification of HER2 and estrogen receptor heterogeneity in breast cancer by single-molecule RNA fluorescence in situ hybridization 107
Expression of the CD31 antigen in normal B-cells and non Hodgkin's lymphomas. 105
Follicular origin of a subset of CD5+ diffuse large B-cell lymphomas 104
DNA vaccination with alpha-enolase effectively prolongs survival in amouse model of human pancreatic cancer. 104
Oncogenic ALK regulates EMT in non-small cell lung carcinoma through repression of the epithelial splicing regulatory protein 1 104
RNAi technology and lentiviral delivery as a powerful tool to suppress Tpr-Met-mediated tumorigenesis 100
Involvement of Grb2 adaptor protein in nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-mediated signaling and anaplastic large cell lymphoma growth. 100
Wiskott–Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma 99
Pure alveolar rhabdomyosarcoma of the corpus uteri: description of a case with increased serum level of CA-125. 96
STAT3β controls inflammatory responses and early tumor onset in skin and colon experimental cancer models. 95
An In vivo Model of Met-Driven Lymphoma as a Tool to Explore the Therapeutic Potential of Met Inhibitors 92
The Down syndrome critical region protein TTC3 inhibits neuronal differentiation via RhoA and Citron kinase 92
BRAF gene is not mutated in plasma cell leukemia and multiple myeloma 91
CD30 expression in anaplastic large cell lymphomas is dependent on ALK tyrosine kinase activity via Stat3 phosphorylation and JunB upregulation 91
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death 89
Of alphas and betas: distinct and overlapping functions of STAT3 isoforms 88
Conditional expression of activated met in differentiated skeletal muscle induces atrophy 87
IL-18 paradox in pancreatic carcinoma: elevated serum levels of free IL-18 are correlated with poor survival 87
Ablation of oncogenic ALK is a viable therapeutic approach fAblation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas 85
Anaplastic Lymphoma Kinase is an effective oncoantigen for lymphoma vaccination 85
The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination 85
ALK-dependent control of hypoxia-inducible factors mediates tumor growth and metastasis 84
Parametri biologici di malignità nei linfomi di piccole cellule CD5 positivi 83
Expression of IFNgammaR2 mutated in a dileucine internalization motif reinstates IFNgamma signaling and apoptosis in human T lymphocytes 83
Anaplastic large-cell lymphoma 82
Molecola perturbation of IFNγR2 internalization reinstates T cell sensitività to the IFNγ/STAT1 signaling pathway in vitro and in vivo. 5th 80
Stat3 is required for anchorage-independent growth and metastasis but not for mammary tumor development downstream of the ErbB-2 oncogene 80
Prognostic value of nucleolar organizer region count in non-invasive thymomas 80
IL17A CRITICALLY SHAPES THE TRANSCRIPTIONAL PROGRAM OF FIBROBLASTS IN PANCREATIC CANCER AND SWITCHES ON THEIR PRO-TUMORIGENIC FUNCTIONS 80
Constitutively active Stat3 triggers the development of autoimmune myocarditis 78
Dissection of critical pathways instrumental for Anaplastic Lymphoma Kinase transformation 77
A Braf kinase-inactive mutant induces lung adenocarcinoma 76
Constitutively active STAT3 triggers the development of autoimmune myocarditis 74
ALK inhibitors and vaccination against anaplastic lymphoma kinase (ALK) induce potent anti-tumor activity improving survival in non small cell lung carcinoma (NSCLC) 74
Anaplastic lymphoma kinase: an oncogene for tumor vaccination 74
NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors. 73
NPM-ALK oncogenic tyrosine kinase controls T-cell identity by transcriptional regulation and epigenetic silencing in lymphoma cells 73
Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes 73
Studio di polimorfismi del DNA in villi coriali isolati mediante microdissezione laser da materiale abortivo: applicazione pratica in un caso giudiziario 72
Identification of genomic and proteomic signatures in lymphomas by inducible shRNA 71
α-enolase, a SERPA-defined antigen elicits both CD4 and CD8 T cell reactivity 69
The role of mechanistic factors in promoting chromosomal translocations found in lymphoid and other cancers. 69
In the absence of IGF-1 signaling, IFN-gamma suppresses human malignant T-cell growth 68
Detection of immunoglobulin kappa light chain rearrangements by polymerase chain reaction. An improved method for detecting clonal B-cell lymphoproliferative disorders. 68
The tyrosine phosphatase Shp2 interacts with NPM-ALK and regulates anaplastic lymphoma cell growth and migration 68
Dissection of critical pathways instrumental to the Anaplastic Lymphoma Kinase oncogenic activity 68
Development of a consensus IgH quantitative assay for the detection of minimal residual disease in Chronic Lymphocytic Leukemia using 3’-minor groove binder probes. 68
S-phase kinase-associated protein 2 expression in non-Hodgkin's lymphoma inversely correlates with p27 expression and defines cells in S phase 68
Identification of the same HRAS1 mutation in a primary minimally invasive follicular carcinoma of the thyroid gland and its bone metastasis developed 15 years later. 67
Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target 66
The anaplastic lymphoma kinase as an oncogene in solid tumors 66
Anaplastic large cell lymphoma: one or more entities among T-cell lymphoma? 64
Induction of germinal centers by MMTV encoded superantigen on B cells. 63
Targeting oncogenic ALK by stable small interfering RNA induces cell death of human Anaplastic Large Cell Lymphoma cells 63
Epitope mapping of spontaneous autoantibodies to anaplastic lymphoma kinase (ALK) in non-small cell lung cancer 63
Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma 63
Type B1 thymoma 62
Argyrophilic nucleolar organizer region counts predict survival in thymoma. 62
The battle against ALK resistance: successes and setbacks. 62
The anaplastic lymphoma kinase in the pathogenesis of cancer 62
Retrovirus-mediated targeting of the Insulin-like Growth Factor-1 Receptor reinstates T lymphocytes sensitivity to the apoptotic effect of IFN-g 61
Selective Therapeutic Targeting of the Anaplastic Lymphoma Kinase With Liposomal siRNA Induces Apoptosis and Inhibits Angiogenesis in Neuroblastoma. 61
Advances in cancer immunology and cancer immunotherapy 61
ALK protein tyrosine kinase, cells and methods embodying and using same 60
In T lymphocytes, ablation of STAT3 expression reinstates STAT1-dependent apoptosis by both IFNg and IL-6 59
Targeting oncogenic ALK by lentiviral small interfering RNA induces growth arrest and apoptosis of human anaplastic large cell lymphoma cells 59
Totale 11.709
Categoria #
all - tutte 40.487
article - articoli 0
book - libri 0
conference - conferenze 6.120
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.607


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.956 0 0 0 215 201 380 236 137 239 185 200 163
2020/20211.580 152 93 128 60 160 66 148 59 198 190 117 209
2021/20221.994 131 107 107 177 122 102 146 111 75 121 418 377
2022/20232.639 317 261 33 270 246 656 188 186 263 58 102 59
2023/20241.178 155 204 69 49 72 169 123 53 12 58 83 131
2024/2025390 35 178 93 84 0 0 0 0 0 0 0 0
Totale 14.113